This exclusive partnership will democratize invaluable insights gleaned from physician interactions to better inform healthcare marketing & decision-making. Los Angeles, California and New York, New York – September 10, 2019 – Pulsar, the leading healthcare insight and social listening solution, is enhancing their TRAC social listening tool with an additional data stream powered by Sermo’s […]
Following Abry Partners investment, the company is poised to enter a growth stage with key areas of focus identified and a strong leadership team in place New York, New York – September 4, 2019 – Sermo, the leading global social platform for physicians and largest healthcare professional survey company, announced today that it has invested […]
- Only 4% believe AI is likely to make psychiatrists’ jobs obsolete
- Only 17% believe AI is likely to replace human empathy
Researchers from major academic centers partnered with Sermo to field the study through Sermo’s global panel of HCPs
Partnership accelerates innovation and adoption for data collection powerhouse and social platform for 800,000+ physicians globally
The FICO score for drugs; First of its kind clinical decision tool now includes 600,000 ratings
Sermo announces new feature for their survey research offering called Dashboard Analytics
Over 2,000 doctors say peer reviews are more credible than information from pharma
Sermo announces new feature for its pioneering Drug Ratings platform
Over 3,000 physicians say Big Pharma, Feds played equal role in opioid epidemic
Close to 800,000 physicians from all seven continents can crowdsource medical information and rate drugs
Drug Ratings gives doctors unprecedented ability to research, choose, and discuss prescription drugs
Only four percent of U.S. doctors think their state has done “very well” implementing telehealth